Growth Factors and their Receptors in Cell Differentiation, Cancer and Cancer Therapy
By: Gajanan Sherbet
Hardcover | 14 July 2011 | Edition Number 1
At a Glance
368 Pages
22.9 x 15.2 x 2.06
Hardcover
RRP $190.95
$148.80
22%OFF
or 4 interest-free payments of $37.20 with
orAims to ship in 5 to 10 business days
Recent years have seen a considerable emphasis on growth factors and the elucidation of their mode of function, which has led to the recognition that growth factors, their receptors as well as downstream elements of signalling associated with their function might be potential targets in therapeutic management of human diseases. Humanised monoclonal antibodies raised against growth factor receptors have proved to be valuable for targeted cancer treatment and in patient management.
This book reviews the latest developments providing insights into the signalling processes involved in morphogenesis and pathogenesis with emphasis on using the elements of the signalling cascades as targets for therapeutic deployment.
-
Provides aÿfundamental understanding of the basic functions of growth factors and their receptors, describing how they are linked in biological processes
-
Aids the development of therapeutic treatments for cancer
-
Focuses on the interrelationships and convergence of growth factors and their receptors in development and pathogenesis and encourages greater cooperation and integration in the areas of developmental, cancer and cancer therapeutic research
Preface | p. xi |
Abbreviations | p. xiii |
Introduction | p. xvii |
Convergence of Growth-Factor Signalling Pathways in Developmental Systems and Pathogenesis | p. 1 |
Growth Factor Families | p. 3 |
The Membrane-Receptor Binding Family of Growth Factors | p. 3 |
Cystine-Knot Group of Growth Factors | p. 3 |
The Intracellular-Receptor Binding Family of Ligands | p. 5 |
Growth Factors in Differentiation and Morphogenesis | p. 7 |
TGF-ß Family Growth Factors in Differentiation and Morphogenesis | p. 8 |
TGF-ß in Tumour Growth, Invasion and Metastases | p. 9 |
The TGF-ß Signalling Cascade | p. 10 |
The TGF-ß Receptor Group | p. 11 |
Receptor Types I and II in Signalling by TGF-ß Ligands | p. 11 |
Receptor Type III Endoglin-Mediated TGF-ß Signalling | p. 11 |
Receptor Type III Betaglycan in TGF-ß Signalling | p. 12 |
The Canonical Smad Pathway | p. 12 |
The Effects of TGF-ß on Cell Proliferation and Apoptosis | p. 13 |
Cell Proliferation, Invasion and Metastasis Mediated by Type III Receptors | p. 15 |
Endoglin as a Chemotherapeutic Target | p. 17 |
Therapeutic Potential of Betaglycan | p. 17 |
TGF-ß and Organ-Specific Metastatic Spread | p. 18 |
Non-Smad (Non-Canonical) Signalling | p. 20 |
Non-Canonical TGF-ß Signalling in Cancer Invasion and Angiogenesis | p. 22 |
MicroRNAs, EMT and TGF-ß Function | p. 23 |
TGF-ß Operates in Other Signalling Systems of Cell Adhesion and Motility | p. 27 |
Interaction between Smad and Non-Smad Signalling | p. 28 |
Signalling Links between BMP, Oestrogen and ER | p. 29 |
Functional Synergy and Regulation between Smad and MAPK Pathways | p. 30 |
Nodal Signalling in Development, Differentiation and Pattern Formation | p. 31 |
Regulation of Nodal Signalling | p. 31 |
Differential Activation of Contributory Pathways | p. 31 |
Selective and Differential Activation of Transcription Factors | p. 32 |
Nodal, miRNA and EMT | p. 34 |
Requirement of Cofactors in Nodal Regulation | p. 34 |
Functional Stability of Nodal | p. 35 |
Bone Morphogenetic Proteins | p. 36 |
Heterogeneity of BMP Signalling Cascade and Phenolypic Effects | p. 38 |
Growth and Differentiation Factors | p. 45 |
GDFs in Development and Differentiation | p. 45 |
Co-ordination of GDF Signalling with Other TGF-ß Family Members | p. 46 |
Synergistic Signalling of GDFs with BMPs | p. 46 |
GDF and Nodal Signalling in Embryonic Development | p. 50 |
Collaborative Function of GDFs and Hormones | p. 51 |
GDF Expression in Cancer | p. 51 |
Activin and Inhibin Signalling | p. 52 |
Signalling Antagonism between Activin and Inhibin | p. 53 |
Vascular Endothelial Growth Factor | p. 55 |
VEGF Signalling | p. 55 |
Angiogenic Properties of VEGF Proximal and Distal Splice Variants | p. 56 |
Synergy of VEGF with Other Angiogenic Signalling Systems | p. 57 |
Notch Signalling in Angiogenesis | p. 58 |
Sphingosine 1-Phosphate (S1P) Cross-Talk in VEGF Signalling | p. 58 |
The Interaction of ADAM Proteins with VEGF Signalling | p. 59 |
Genetic Polymorphism in VEGF in Disease Slates | p. 59 |
Is the Production of SNPs and VEGF Linked? | p. 60 |
Functional Synergy of SNPs of Angiogenic Agents | p. 60 |
Neovascularisation and Tumour Progression | p. 61 |
Targeting VEGF and VEGFR in Cancer Treatment | p. 62 |
Hepatocyte Growth Factor | p. 65 |
Molecular Structure of HGF | p. 65 |
HGF/MET Signalling | p. 65 |
MET as a Therapeutic Target | p. 69 |
The Platelet-Derived Growth Factor Family | p. 71 |
PDGF in Cell Transformation and Cancer | p. 72 |
Putative Collaborative Participation of PDGF in Angiogenic Signalling | p. 72 |
PDGF and Epithelial-Mesenchymal Transition | p. 72 |
PDGF Signalling in Cell Proliferation and Migration | p. 74 |
Co-operation with GPCR Pathway in Mitogenic Function | p. 75 |
Signalling Specificity | p. 75 |
PDGF Activates ets-1 Transcription Factor | p. 75 |
Early Growth Response (egr) Zinc Finger Transcription Factors | p. 76 |
MCP-1 in PDGF Effect | p. 77 |
Relationship of PDGF Expression to Cancer Invasion and Progression | p. 78 |
Genetic Changes in PDGFs and PDGFRs | p. 79 |
Nerve Growth Factors | p. 81 |
NT Signalling | p. 81 |
Genetic Alterations in NT Receptors | p. 82 |
Expression of NTs and Their Receptors in Cancer | p. 84 |
Insulin-Like Growth Factors | p. 87 |
Insulin-Like Growth Factors and Their Receptors | p. 87 |
Insulin-Like Growth Factor Receptors | p. 87 |
Insulin Receptor Substrate Proteins | p. 87 |
IGF Signalling Pathways | p. 88 |
IGF Signalling Interacts with Other Signalling Systems | p. 90 |
The Interaction of Insulin and Growth Hormone with IGF Signalling | p. 90 |
IGF Cross-Talk with Cell Proliferation and Migration Signalling | p. 92 |
IGF Induces VEGF Expression and Vascularisation | p. 93 |
Integration of Notch Signalling by IGF | p. 95 |
IGF and the Morphogenetic Function of Wnt Proteins | p. 96 |
Leptin Synergy with IGF Function | p. 97 |
IGF Expression in Cancers | p. 100 |
Modulation of Migration by IGFs and Their Receptors | p. 102 |
Connective Tissue Growth Factor | p. 105 |
CTGF in Wound Healing and Fibrosis | p. 105 |
CTGF Expression Correlates with Cancer Progression and Prognosis | p. 106 |
Is CTGF Involved in Osteotropic Metastasis? | p. 107 |
Pro-angiogenic Effect of CTGF | p. 108 |
Regulation of CTGF by TGF-ß | p. 109 |
Thrombospondins | p. 111 |
TSPs in Cancer | p. 112 |
Cytokines | p. 115 |
Tumour Necrosis Factors | p. 115 |
TNF, Cell Proliferation and Apoptosis | p. 117 |
TNF, Angiogenesis, Cancer Invasion and Metastasis | p. 117 |
Targeting TNF- Function through MicroRNAs | p. 119 |
Interleukins | p. 119 |
Interleukins Induce Cell Motility | p. 120 |
Angiogenic Effects of Interleukins | p. 121 |
Interferons | p. 122 |
IFNs in Cancer Progression | p. 123 |
Cytokines and Myeloid Differentiation | p. 124 |
Granulocyte-Macrophage (GM-CSF), Granulocyte (G-CSF) and Macrophage (M-CSF) Colony-Stimulating Factors | p. 125 |
Cytokines in Cancer Therapy | p. 126 |
Chemokines | p. 128 |
IFN-Induced Chemokines in Cancer Invasion | p. 129 |
Monocyte Chemoattractant Protein (MCP) | p. 131 |
MCP-1 Expression in Cancers | p. 131 |
Growth Factor and Hedgehog Signalling Pathways Meet in Developmental Systems | p. 133 |
The Hedgehog (Hh) Proteins | p. 133 |
The Hh Signalling Cascade | p. 134 |
Hh Homologues and Their Role in Morphogenesis | p. 136 |
Co-operative Signalling by Hh and Growth Factors | p. 138 |
TGF-ß Family Ligands and Hh Signalling | p. 138 |
FGF and Hh Signalling | p. 139 |
Epidermal Growth Factors and Their Signalling Systems | p. 141 |
Growth Factor Signal Transduction | p. 141 |
Epidermal Growth Factor (EGF) Family Ligands and Receptors | p. 141 |
EGF Signalling Pathways | p. 144 |
EGF Signalling through CD44 | p. 147 |
GPCRs in Growth Factor Signalling | p. 149 |
The Wnt/ß-catenin Pathway in Growth Factor Signalling | p. 150 |
Hedgehog Signalling in EGFR Function | p. 151 |
Negative Regulation of EGFR Signalling | p. 152 |
Preferential Receptor Activation and Transactivation | p. 153 |
Metastasis Suppressor Genes and Growth Factor Signalling | p. 154 |
Nm23 Interaction with Growth Factor Function | p. 156 |
Growth Factor Receptor Expression in Cancer | p. 160 |
EGF Family Receptors in Cancer Therapy | p. 161 |
Treatment of Triple-negative Breast Cancer | p. 165 |
The Epidermal Growth Factor (EGF) Family | p. 173 |
Structure, Function and Expression of Epidermal Growth Factor (EGF) and EGF Receptor | p. 173 |
Single Nucleotide Polymorphism of EGF and Its Significance | p. 174 |
Function of Transforming Growth factor (TGF)- | p. 176 |
Neuregulins (Heregulins) | p. 178 |
Amphiregulin (AREG) | p. 183 |
Differential Signalling by AREG | p. 183 |
AREG in Cell Proliferation | p. 184 |
AREG in Invasion and Metastasis | p. 185 |
AREG Expression in Human Neoplasms | p. 191 |
Epiregulin (EREG) | p. 192 |
EREG Expression in Cancers | p. 193 |
ß-Cellulin (BTC) | p. 194 |
BTC Expression in Cancers | p. 195 |
Heparin-Binding Epidermal Growth Factor-Like Growth Factor | p. 195 |
HB-EGF Induces Angiogenesis | p. 195 |
Influence of HB-EGF on Cell Motility and Invasion | p. 196 |
HB-EGF in Cancer Progression | p. 197 |
The Fibroblast Growth Factor Family | p. 199 |
FGFs in the Development of the Central Nervous System and Neuronal Differentiation | p. 201 |
FGF2 (Basic FGF) | p. 204 |
FGF2-Mediated Promotion of Intercellular Adhesion | p. 205 |
FGF2 and Promotion of Neurite Extension | p. 205 |
FGF2 and Osteogenesis | p. 207 |
FGFs 1 and 2 Regulate Cell Proliferation | p. 208 |
FGFs 1 and 2 and the Induction of Angiogenesis | p. 208 |
Intracellular Receptor Binding Growth Factors | p. 211 |
The Androgens and Androgen Receptors in Development, Differentiation and Neoplasia | p. 213 |
Androgen Receptor and Androgen-Responsive Elements | p. 213 |
AR-Activated Signalling Pathways | p. 214 |
AR Expression in Cancer Progression | p. 216 |
Functional Integrity of AR and AR-Mediated Signalling | p. 217 |
Interaction of Androgen and Growth Factor Signalling | p. 217 |
Vitamin D3 in Cell Proliferation, Apoptosis and Differentiation | p. 219 |
The VD3 Receptor, VDRs and VDR Response Elements | p. 219 |
VDR Signalling in Cell Proliferation, Apoptosis and Differentiation | p. 220 |
Modulation of Cell Adhesion and Motility | p. 221 |
Collaborative Function of VDR and RA Receptors | p. 223 |
Retinoids in Development and Pattern Formation | p. 225 |
Retinoic Acid Receptors | p. 225 |
RAR-Mediated Biological Effects | p. 225 |
Oestrogens and Progesterone in Normal Physiology and Neoplasia | p. 229 |
Receptor Mediation of Oestrogen and Progesterone Function | p. 229 |
ER/PR in Cell Adhesion, Proliferation and Cross-talk with Growth Factor Signalling | p. 230 |
ER Signalling and Cell Motility | p. 230 |
ER and Cell Proliferation | p. 231 |
ER/PR Cross-talk with Tumour Suppressor and Promoter Signalling | p. 232 |
The Trefoil Protein TFF1 | p. 234 |
TFF1, Cell Proliferation and Invasion | p. 234 |
TFFs in Progression and Prognosis | p. 235 |
Glucocorticoid Signalling in Normal and Aberrant Physiology | p. 237 |
Glucocorticoid Receptors in Signalling | p. 237 |
Effects of Glucocorticoids on Cell Function | p. 239 |
Regulation of Cell Proliferation | p. 239 |
Modulation of Extracellular Matrix Enzyme Systems | p. 240 |
Glucocorticoids and Cancer Progression | p. 241 |
Epilogue | p. 243 |
References | p. 249 |
Table of Contents provided by Ingram. All Rights Reserved. |
ISBN: 9780123878199
ISBN-10: 0123878195
Series: Elsevier Insights
Published: 14th July 2011
Format: Hardcover
Language: English
Number of Pages: 368
Audience: College, Tertiary and University
Publisher: ELS AMST ORIGIN USA
Country of Publication: US
Edition Number: 1
Dimensions (cm): 22.9 x 15.2 x 2.06
Weight (kg): 0.66
Shipping
Standard Shipping | Express Shipping | |
---|---|---|
Metro postcodes: | $9.99 | $14.95 |
Regional postcodes: | $9.99 | $14.95 |
Rural postcodes: | $9.99 | $14.95 |
How to return your order
At Booktopia, we offer hassle-free returns in accordance with our returns policy. If you wish to return an item, please get in touch with Booktopia Customer Care.
Additional postage charges may be applicable.
Defective items
If there is a problem with any of the items received for your order then the Booktopia Customer Care team is ready to assist you.
For more info please visit our Help Centre.
You Can Find This Book In
Smart and Intelligent Nanostructured Materials for Next-Generation Biosensors
Micro & Nano Technologies
Paperback
RRP $396.95
$299.75
OFF
Leveraging Metaverse and Analytics of Things (AoT) in Medical Systems
Advances in ubiquitous sensing applications for healthcare
Paperback
RRP $264.95
$199.95
OFF
This product is categorised by
- Non-FictionMedicinePre-Clinical Medicine & Basic SciencesHuman Reproduction, Growth & DevelopmentReproductive MedicineEmbryology
- Non-FictionScienceBiology, Life SciencesBiochemistry
- Non-FictionMedicineNursing & Ancillary ServicesBiomedical Engineering
- Non-FictionScienceBiology, Life SciencesLife Sciences in GeneralGenetics excluding Medical
- Non-FictionScienceBiology, Life SciencesDevelopmental Biology
- Non-FictionMedicineClinical & Internal MedicineDiseases & DisordersOncology